Do you want to read an article? Please log in or register.
Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study
Hepatology
Related content
Hepatology
Nonalcoholic Fatty Liver Disease Increases Risk of Incident Chronic Kidney Disease: a Systematic Review and Meta-Analysis
Metabolism.
Mantovani A, Zaza G, Byrne CD, Lonardo A, Zoppini G, Bonora E, Targher G
doi: 10.1016/j.metabol.
Hepatology
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation
Liver Transpl
Younossi ZM
doi: 10.1002/lt.25003.
Hepatology
Nonalcoholic Fatty Liver Disease and the Incidence of Myocardial Infarction: A Cohort Study
J Gastroenterol Hepatol.
Sinn DH, Kang D, Chang Y, Ryu S, Cho SJ, Paik SW, Song YB, Pastor-Barriuso R, Guallar E, Cho J, Gwak GY
doi: 10.1111/jgh.14856.
Hepatology
Fibrosis-4 Index vs Nonalcoholic Fatty Liver Disease Fibrosis Score in Identifying Advanced Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease: A Meta-Analysis
Am J Gastroenterol
Castellana M, Donghia R, Guerra V, Procino F, Castellana F, Zupo R, Lampignano L, Sardone R, De Pergola G, Romanelli F, Trimboli P, Giannelli G
doi: 10.14309/ajg.0000000000001337
Hepatology
Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease: A Longitudinal Cohort Study
Am J Gastroenterol.
Allen AM, Therneau TM, Mara KC, Larson JJ, Watt KD, Hayes SN, Kamath PS
doi: 10.14309/ajg.0000000000000401.
COMMENTED
Gastrointestinal CancerHepatology
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
N Engl J Med
Sanyal AJ, Van Natta ML, Clark J, Neuschwander-Tetri BA, Diehl A, Dasarathy S, Loomba R, Chalasani N, Kowdley K, Hameed B, Wilson LA, Yates KP, Belt P, Lazo M, Kleiner DE, Behling C, Tonascia J, NASH Clinical Research Network (CRN).
doi: 10.1056/NEJMoa2029349
Hepatology
The Enhanced Liver Fibrosis test is associated with liver-related outcomes in postmenopausal women with risk factors for liver disease
BMC Gastroenterol.
Trembling PM, Apostolidou S, Gentry-Maharaj A, Parkes J, Ryan A, Tanwar S, Burnell M, Harris S, Menon U, Rosenberg WM
doi: 10.1186/s12876-020-01251-w.
Further Publications
Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States
J Hepatol
Kim D, Konyn P, Sandhu KK, Dennis BB, Cheung AC, Ahmed A
doi: 10.1016/j.jhep.2021.07.035
Hepatology
Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality
Am J Gastroenterol.
Kim D, Vazquez-Montesino LM, Escober JA, Fernandes CT, Cholankeril G, Loomba R, Harrison SA, Younossi ZM, Ahmed A
doi: 10.14309/ajg.0000000000000654.